Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2022 | 3 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab.
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):4024-4035. doi: 10.1007/s00259-023-06394-y. Epub 2023 Aug 22.
Eur J Nucl Med Mol Imaging. 2023.
PMID: 37606858
Ultra-low-dose in brain 18F-FDG PET/MRI in clinical settings.
Soret M, Maisonobe JA, Desarnaud S, Bergeret S, Causse-Lemercier V, Berenbaum A, Rozenblum L, Habert MO, Kas A.
Soret M, et al. Among authors: berenbaum a.
Sci Rep. 2022 Sep 12;12(1):15341. doi: 10.1038/s41598-022-18029-7.
Sci Rep. 2022.
PMID: 36097015
Free PMC article.
Item in Clipboard
Radiation dose to nuclear medicine technologists when operating PET/MR compared with PET/CT.
Soret M, Maisonobe JA, Payen S, Gaubert A, Brunel S, Bergeret S, Berenbaum A, Hubert E, Kas A.
Soret M, et al. Among authors: berenbaum a.
J Radiol Prot. 2022 Apr 27;42(2). doi: 10.1088/1361-6498/ac5e50.
J Radiol Prot. 2022.
PMID: 35296565
Item in Clipboard
Hybrid [18F]-F-DOPA PET/MRI Interpretation Criteria and Scores for Glioma Follow-up After Radiotherapy.
Bertaux M, Berenbaum A, Di Stefano AL, Rozenblum L, Soret M, Bergeret S, Hoang-Xuan K, Tainturier LE, Sgard B, Habert MO, Delattre JY, Dehais C, Idbaih A, Pyatigorskaya N, Kas A.
Bertaux M, et al. Among authors: berenbaum a.
Clin Neuroradiol. 2022 Sep;32(3):735-747. doi: 10.1007/s00062-022-01139-0. Epub 2022 Feb 11.
Clin Neuroradiol. 2022.
PMID: 35147721
Item in Clipboard
Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors.
Seban RD, Mezquita L, Berenbaum A, Dercle L, Botticella A, Le Pechoux C, Caramella C, Deutsch E, Grimaldi S, Adam J, Ammari S, Planchard D, Leboulleux S, Besse B.
Seban RD, et al. Among authors: berenbaum a.
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1147-1157. doi: 10.1007/s00259-019-04615-x. Epub 2019 Nov 21.
Eur J Nucl Med Mol Imaging. 2020.
PMID: 31754795
Item in Clipboard
Cite
Cite